- companies hurt by declining sales of prescription drugs
- more than seven thousand jobs being lost
-job cuts supposed to help the oncoming recession
- inability to make new drugs
-sales expected to grow 2% to 4% over a five year time period
-pharmaceutical companies have cut about hundred thousand jobs in the last five years
- Merck now has 56,700 employees, but in 2005 cut 10,400 jobs which were part of a reorganization
- they started a reorganization because the companies Viozz pain reliever was taken off the market for safety concerns
-Merck shares down 6.5%
- cuts will end in 2011
-senior and mid level executives will be cut by 25%
-three research sites will be closed: Seattle, Italy, and Japan by the end of 2009
-meant to save company 3.8 billion to 4.2 billion
- but will cost them 1.6 - 2 billion in reorganization charges, and severance pay to do so
-Richard T. Clark said that it was to help make a position for Merck in the future
-the company wants to speed up innovation by focusing on on particular research on special diseases
- the same happened with cholesterol- lowering drugs dropping 15%
-this happened because studies found that there drug wasn't very effective
-sales of asthma and allergy drugs only increased my 1%
- sales of cervical cancer vaccine, Gardasil decreased by 4% because of the cost for it
- Merck's earnings fell 51 cents for each share the company had.
-Merck's osteoporosis drug plunged 51% in the quarter
- the company is planning to do more in biotechnology drugs
- they represent the industry's biggest sellers
- they are wanting to be similar to Epogen and Neupogen the big sellers